Publication | Closed Access

First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody

Translational MedicineUrologyRenal FunctionMedicineFirst-in-human ValidationBioanalysisChronic Kidney DiseaseEnzymolysis Clearance StrategyRadiopharmaceutical TherapyRenal RadioactivityNephrologyClinical ChemistryMetabolismPharmacologyNuclear MedicineKidney Research